Surmounting Withdrawal to Initiate Fast Treatment with Naltrexone (SWIFT): A stepped wedge hybrid type 1 effectiveness-implementation study.

MLA

Greiner, Miranda G., et al. “Surmounting Withdrawal to Initiate Fast Treatment with Naltrexone (SWIFT): A Stepped Wedge Hybrid Type 1 Effectiveness-Implementation Study.” Contemporary Clinical Trials, vol. 128, May 2023, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.cct.2023.107148.

APA

Greiner, M. G., Shulman, M., Opara, O., Potter, K., Voronca, D. C., Tafessu, H. M., Hefner, K., Hamilton, A., Scheele, C., Ho, R., Dresser, L., Jelstrom, E., Fishman, M., Ghitza, U. E., Rotrosen, J., Nunes, E. V., & Bisaga, A. (2023). Surmounting Withdrawal to Initiate Fast Treatment with Naltrexone (SWIFT): A stepped wedge hybrid type 1 effectiveness-implementation study. Contemporary Clinical Trials, 128, N.PAG. https://doi.org/10.1016/j.cct.2023.107148

Chicago

Greiner, Miranda G., Matisyahu Shulman, Onumara Opara, Kenzie Potter, Delia C. Voronca, Hiwot M. Tafessu, Kathryn Hefner, et al. 2023. “Surmounting Withdrawal to Initiate Fast Treatment with Naltrexone (SWIFT): A Stepped Wedge Hybrid Type 1 Effectiveness-Implementation Study.” Contemporary Clinical Trials 128 (May): N.PAG. doi:10.1016/j.cct.2023.107148.